[
  {
    "title": "STAT+: 5 powerful people to know at HHS",
    "link": "https://www.statnews.com/2026/02/19/powerful-people-at-hhs-oz-talks-with-pharma-dc-diagnosis-newsletter/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-19T17:13:14.000Z",
    "summary": "Find out who's on the rise inside RFK Jr.'s federal health department."
  },
  {
    "title": "Altesa, run by former Trump official, raises $75M for well-traveled lung drug",
    "link": "https://www.biopharmadive.com/news/Altesa-biotech-startup-financing-giroir-vapendavir-copd-lung/812566/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-19T17:06:00.000Z",
    "summary": "Led by Brett Giroir and GSK’s ex-chief medical officer, Altesa is advancing a medicine that’s changed hands multiple times and once failed a study in asthma."
  },
  {
    "title": "FDA leaders say one pivotal trial, not two, should be ‘default’ for drug approvals",
    "link": "https://www.biopharmadive.com/news/fda-makary-prasad0one-pivotal-trial-nejm/812557/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-19T16:20:00.000Z",
    "summary": "In a NEJM article, Commissioner Martin Makary and top deputy Vinay Prasad argued that the new policy should lower development costs and speed development without compromising agency standards."
  },
  {
    "title": "STAT+: AI-guided cancer treatments, telehealth usage, and other health tech news",
    "link": "https://www.statnews.com/2026/02/19/ai-guided-cancer-treatment-telehealth-usage-health-tech/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-19T14:25:49.000Z",
    "summary": "In this edition of STAT Health Tech: A new wave of AI-guided cancer treatments, a Hims acquisition, and other health tech news."
  },
  {
    "title": "STAT+: Pharmalittle: We’re reading about the FDA pushing OTC meds, its new trial standards, and much more",
    "link": "https://www.statnews.com/pharmalot/2026/02/19/fda-otc-trials-jnj-novo-obesity-antibiotics-hims-hiv/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-19T14:08:32.000Z",
    "summary": "FDA Commissioner Marty Makary said he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires monitoring"
  },
  {
    "title": "Does the world need ‘guy-necologists’?",
    "link": "https://www.statnews.com/2026/02/19/health-news-pap-smear-men-fertility-semen-analysis/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-19T13:05:28.000Z",
    "summary": "And other health news from the Morning Rounds newsletter"
  },
  {
    "title": "STAT+: Hims to buy Eucalyptus as it looks to expand globally",
    "link": "https://www.statnews.com/2026/02/19/hims-acquire-eucalyptus-telehealth-international/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-19T11:48:12.000Z",
    "summary": "Hims & Hers is buying the Australian telehealth firm Eucalyptus as it looks to make inroads in more countries globally."
  },
  {
    "title": "STAT+: What to expect from Gossamer Bio’s late-stage lung disease study",
    "link": "https://www.statnews.com/2026/02/19/gossamer-bio-promis-neurosciences/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-19T11:30:00.000Z",
    "summary": "Gossamer Bio will be reporting the outcome of a late-stage study in pulmonary arterial hypertension. Here's what to know."
  },
  {
    "title": "STAT+: 5 key people to watch at HHS after Trump’s shake-up",
    "link": "https://www.statnews.com/2026/02/19/hhs-leadership-shuffle-five-top-officials-to-watch/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-19T09:30:00.000Z",
    "summary": "HHS has elevated a new team of health policy experts, including a former health IT exec and a Trump administration veteran."
  },
  {
    "title": "Opinion: My biggest GLP-1 ethical problem: patients who don’t want to stop",
    "link": "https://www.statnews.com/2026/02/19/glp-1-weight-loss-drugs-eating-disorders-doctor/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-19T09:30:00.000Z",
    "summary": "Some GLP-1 patients are begging to stay on the drugs just a little bit longer, presenting an ethical dilemma for doctors."
  },
  {
    "title": "Opinion: I took part in a 2012 psilocybin trial. What I’m seeing now horrifies me",
    "link": "https://www.statnews.com/2026/02/19/psychedelic-therapy-more-than-just-drugs/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-19T09:30:00.000Z",
    "summary": "“I took part in a 2012 psilocybin trial. What I’m seeing now horrifies me,” writes Erica Rex, author of the new book “Seeing What Is There.”"
  },
  {
    "title": "Should semen analysis become the Pap smear for men? Some men’s health experts say yes",
    "link": "https://www.statnews.com/2026/02/19/semen-analysis-startups-pitch-male-version-pap-smear/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-19T09:30:00.000Z",
    "summary": "A \"guy-necologist\" makes a case that semen analysis should become a regular part of men's medical care."
  },
  {
    "title": "STAT+: New FDA guidance for antibiotic use in food-producing animals prompts criticism over antibiotic resistance",
    "link": "https://www.statnews.com/pharmalot/2026/02/18/fda-livestock-guidance-antibiotic-resistance-cows-pigs-chickens/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T21:45:29.000Z",
    "summary": "New FDA guidance on the use of antibiotics in food-producing animals has prompted criticism that it fails to consider the impact on human health."
  },
  {
    "title": "STAT+: NIH Director Bhattacharya to lead CDC after O’Neill’s exit",
    "link": "https://www.statnews.com/2026/02/18/cdc-acting-director-jay-bhattacharya/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T18:48:30.000Z",
    "summary": "He's the third leader of the public health agency since this summer."
  },
  {
    "title": "Upcoming meeting of federal vaccine panel may be postponed after HHS missed deadlines",
    "link": "https://www.statnews.com/2026/02/18/cdc-vaccines-acip-meeting-may-be-postponed/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T17:09:21.000Z",
    "summary": "Federal officials have missed the legal deadline to notify the public of an upcoming ACIP meeting, raising questions about whether the meeting will be postponed."
  },
  {
    "title": "STAT wins fourth Polk Award for reporting on impact of Trump on health",
    "link": "https://www.statnews.com/2026/02/18/stat-wins-polk-award-reporting-trump-science-fda/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T16:45:14.000Z",
    "summary": "STAT has won its fourth Polk Award in five years for documenting the Trump administration’s shakeup of the FDA, scientific research, and public health."
  },
  {
    "title": "Lilly to pay CSL $100M to license monoclonal antibody targeting IL-6",
    "link": "https://www.biopharmadive.com/news/lilly-deal-csl-100m-license-monoclonal-antibody-targeting-il-6/812455/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-18T16:15:18.000Z",
    "summary": "The Australian company will retain rights for an end-stage kidney disease indication currently being tested in a Phase 3 trial while Lilly explores other uses."
  },
  {
    "title": "STAT+: AI Prognosis: Who’s keeping tabs on how health insurers are using AI?",
    "link": "https://www.statnews.com/2026/02/18/health-insurers-using-artificial-intelligence-ai-prognosis/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T15:43:06.000Z",
    "summary": "In this edition, AI Prognosis talks to STAT's Casey Ross, a Pulitzer finalist laser-focused on health insurers' use of AI, and more."
  },
  {
    "title": "FDA accepts BMS protein degrader for review; Disc rare disease drug rejected",
    "link": "https://www.biopharmadive.com/news/disc-news-roundup-pharma-biotech/812351/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-18T15:35:17.000Z",
    "summary": "Cytokinetics’ heart disease drug secured European approval. Elsewhere, Teva and Sanofi reported longer-term data from an experimental therapy targeting ulcerative colitis and Crohn’s disease."
  },
  {
    "title": "An Alzheimer’s startup emerges with $175M in venture backing",
    "link": "https://www.biopharmadive.com/news/korsana-alzheimers-amyloid-beta-plaque-launch/812443/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-18T15:22:54.000Z",
    "summary": "Backed by Wellington, Sanofi Ventures and a division of J.P. Morgan, Korsana Therapeutics is studying a treatment originally developed by hub-and-spoke biotech Paragon Therapeutics."
  },
  {
    "title": "STAT+: Investors cheer Compass’ psilocybin data",
    "link": "https://www.statnews.com/2026/02/18/biotech-news-investors-celebrate-compass-psilocybin-data/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T15:01:52.000Z",
    "summary": "And other biotech news brought to you by The Readout"
  },
  {
    "title": "STAT+: Pharmalittle: We’re reading about an FDA reversal on a Moderna vaccine, the U.K. life sciences sector, and more",
    "link": "https://www.statnews.com/pharmalot/2026/02/18/fda-moderna-vaccines-hhs-kennedy/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T14:41:09.000Z",
    "summary": "The FDA reversed course and told Moderna it would review its application for a new flu vaccine, after refusing to do so earlier this month"
  },
  {
    "title": "Psychedelics stocks rise as Compass’ psilocybin drug heads to FDA",
    "link": "https://www.biopharmadive.com/news/psychedelics-stocks-rise-as-compass-psilocybin-drug-heads-to-fda/812441/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-18T14:25:25.000Z",
    "summary": "Shares of at least four other developers were up by mid-single digits to low-double digits at certain points on Tuesday."
  },
  {
    "title": "FDA reverses course on Moderna’s flu vaccine",
    "link": "https://www.biopharmadive.com/news/fda-reverses-course-review-moderna-approval-application-influenza-/812432/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-18T14:24:47.000Z",
    "summary": "In response to a query from BioPharma Dive, an HHS spokesperson said the FDA will “maintain its high standards during drug review and potential licensure stages.”"
  },
  {
    "title": "STAT+: The FDA’s Moderna pirouette is one more sign of chaos at the agency",
    "link": "https://www.statnews.com/2026/02/18/moderna-fda-reversal-vinay-prasad/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T14:00:45.000Z",
    "summary": "For drugmakers and vaccine developers, an FDA reversal on Moderna's flu vaccine is better than the alternative. But it is also another sign of agency chaos."
  },
  {
    "title": "Proposed $7.25B settlement to resolve weedkiller cancer lawsuits",
    "link": "https://www.statnews.com/2026/02/18/health-news-roundup-weedkiller-cancer-lawsuit/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T12:58:06.000Z",
    "summary": "And other health news from the Morning Rounds newsletter"
  },
  {
    "title": "STAT+: FDA reverses course, agrees to review Moderna’s flu vaccine",
    "link": "https://www.statnews.com/2026/02/18/fda-moderna-reverse-course-flu-vaccine/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-18T12:29:42.000Z",
    "summary": "The FDA reversed course and told Moderna it would review its application for a new flu vaccine, the company announced Wednesday."
  },
  {
    "title": "PIP4K2C: an emerging fulcrum for multiple diseases",
    "link": "https://www.nature.com/articles/d41573-026-00030-8",
    "source": "Nature Reviews Drug Discovery",
    "category": "research",
    "date": "2026-02-18T00:00:00.000Z",
    "summary": ""
  },
  {
    "title": "Compass, with Phase 3 hits, ready to take psilocybin to the FDA",
    "link": "https://www.biopharmadive.com/news/compass-trial-data-fda-application-psilocybin-psychedelics/812332/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-17T16:53:15.000Z",
    "summary": "The company plans to meet with the FDA to discuss a rolling approval application for “COMP360,” a synthetic form of psilocybin that could become the first “classic” psychedelic cleared for the U.S.…"
  },
  {
    "title": "Ocular claims a win with eye drug data even as shares sink",
    "link": "https://www.biopharmadive.com/news/ocular-therapeutix-succeeded-phase-3-eye-drug-data-axpaxli-eylea/812329/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-17T16:07:37.000Z",
    "summary": "Investors were looking for a greater difference between Ocular’s experimental medicine and a low-dose version of Eylea, analysts said."
  },
  {
    "title": "Selecting the optimal cell therapy manufacturing platform",
    "link": "https://www.biopharmadive.com/spons/selecting-the-optimal-cell-therapy-manufacturing-platform/812042/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-17T10:00:00.000Z",
    "summary": "Navigating modular vs. integrated platforms—find the best path for your cell therapy program."
  },
  {
    "title": "Therapeutic targeting of neuroimmune mechanisms in neurodegeneration",
    "link": "https://www.nature.com/articles/s41573-025-01370-7",
    "source": "Nature Reviews Drug Discovery",
    "category": "research",
    "date": "2026-02-16T00:00:00.000Z",
    "summary": ""
  },
  {
    "title": "TIGIT’s immuno-oncology teachings",
    "link": "https://www.nature.com/articles/d41573-026-00031-7",
    "source": "Nature Reviews Drug Discovery",
    "category": "research",
    "date": "2026-02-16T00:00:00.000Z",
    "summary": ""
  },
  {
    "title": "Approvals by the China NMPA in 2025",
    "link": "https://www.nature.com/articles/d41573-026-00028-2",
    "source": "Nature Reviews Drug Discovery",
    "category": "research",
    "date": "2026-02-13T00:00:00.000Z",
    "summary": ""
  }
]
